A Pfizer employee showed up on the campus of Harvard Medical School and took a photograph of medical students demonstrating against commercial influence over their education. But who is the employee (pictured) and what was he doing on campus? If you know the answer, please tell BNET either through the mail form here or directly at jimedwards123@hotmail.com. We will not reveal your identity. ...
Pharma Industry Archive
March 2009
AstraZeneca knew as far back as 1997 that Seroquel put patients at risk of weight gain, according to the company’s own internal memos. The documents also appear to show that some AZ execs developed strategies to “neutralize” information that suggested Seroquel caused weight gain or diabetes, even after the FDA asked the company to warn patients about Seroquel’s diabetes...
How bad could that Texas lawsuit against Johnson & Johnson for mismarketing Risperdal be? Try $5,000 per visit of a sales rep to a doctor. That was the formula used in a West Virginia state court case in which the state attorney general sued J&J and its Janssen Pharmaceutica unit over false or misleading statements about Risperdal and Duragesic. The West Virginia judge assessed only...
Five drug and device companies, plus their lobbyist, PhRMA, are all very, very concerned about the welfare of Utah families. So concerned they gave $172,400 to the Utah Family Foundation over the last few years. By amazing coincidence, the foundation was founded by Sen. Orrin Hatch, who has long made legislative efforts favoring Big Pharma and whose son is employed as a lobbyist by PhRMA. The...
The FDA gave GlaxoSmithKline a lesson in geometry last week when it sent the company a warning letter over its “misleading” claims for Avodart, a prostate reduction drug. FDA’s main objection was the scale of the animation in the Avodart ad that was supposed to represent a man’s shrinking prostate. GSK used some model planets from the solar system to illustrate the...
- Novartis Looks at Combination Pills to Fix Hypertension Franchise
- Study Showing Drug Ads Are Linked to Higher Prices Has Flaws
- Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them
- Pfizer Got $160M in Tax Money to Build in Connecticut
- Sanofi's Viehbacher Backs Health Reform; May Change Company's Name
- Viagra Now Available Intravenously
- Genzyme Kidney Drug Failed, Too...What Could Possibly Happen Next?
- Peter Pitts' CMPI Targeted Over Anti-Healthcare Reform Video Game
- Why Allergan and Medicis Should Embrace the "Botox Tax" in Senate Health Bill
- Why J&J's Stelara Launch Should Target Dermatologists First
- NHS Loses Fight Over Publication of Antipsychotic Meds Brochures for Kids
- Genzyme's Termeer Got $50M in Compensation Over Last 3 Years; Wife Got Trips to Asia on Corporate Jet
- Merck Gives Snapshot of Combined Company: $47B in Sales; Just $7.6B in Cash
- Why Pfizer Wants Your Car-Sick Dog to Travel on Thanksgiving
- FDA Delays Genzyme's Lumizyme, Manufacturing Problems Blamed
- Will FDA Approve MannKind's Insulin Inhaler?
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted
- Hepatitis C Drugs Kill the Virus...and Your Sex Drive
- Microchip Implant to Link Your Health Records, Credit History, Social Security
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
- NYT's MannKind Story Needlessly Quoted a Competitor Bashing Afresa
- Novartis CEO Sends Emails to 140 Animal Rights Activists:
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low
Subscribe to Pharma blog comments RSS 
- How NOT to Write a Biotech Press Release: Just Ask Epeius
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity"
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
- The 10 Weirdest Drug Stories of the Month
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone
Industry Transcripts by Seeking Alpha
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Archives
Recommended Sources
About Pharma Industry
BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.